Is this you? Create Your Porfile
Avatar

Egerland Ute

Janssen Pharmaceutica

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Egerland Ute is active.

Explore More

Publication

Featured researches published by Egerland Ute.

Archive | 2003

AMIDES OF CYCLIC AMINO ACIDS USED AS PDE 4 INHIBITORS

Egerland Ute; Rueger Carla; Schindler Rudolf; Rundfeldt Chris; Kuss Hildegard; Lichoscherstow Arkadi M; Seredenin Sergey B; Borissenko Sergey A

Archive | 2017

TRIAZOLES AS NR2B RECEPTOR INHIBITORS

Schindler Rudolf; Lankau Hans-Joachim; Hofgen Norbert; Egerland Ute; Langen Barbara; Dost Rita; Ward Simon

Archive | 2016

4-METHYL-2,3,5,9,9B-PENTAAZA-CYCLOPENTA[A]NAPHTHALENES 4--23599B--[A]

Giovannini Riccardo; Bertani Barbara; Frattini Sara; Di Antonio Giustino; Lankau Hans-Joachim; Stange Hans; Grunwald Christian; Hfgen Norbert; Langen Barbara; Egerland Ute

Archive | 2015

Compuestos derivados de 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos, inhibidores de fosfodiestearasa 2 y/o 10; composicion farmaceutica; y su uso para prevencion o tratamiento de enfermedades del sistema nervioso, como deficiencia cognitiva, demencia, trastornos de ansiedad, enf. de alzheimer, enf. de parkinson, otros

Giovannini Riccardo; Bertani Barbara; Frattini Sara; Di Antonio Giustino; Lankau Hans-Joachim; Stange Hans; Grunwald Christian; Hofgen Norbert; Langen Barbara; Egerland Ute

Archive | 2015

4-METIL-2,3,5,9,9B-PENTAAZA-CICLOPENTA[A]NAFTALENOS

Giovannini Riccardo; Bertani Barbara; Frattini Sara; Di Antonio Giustino; Lankau Hans-Joachim; Stange Hans; Grunwald Christian; Hofgen Norbert; Langen Barbara; Egerland Ute

Archive | 2014

DERIVES DE (1,2,4) TRIAZOLO[4,3-A]QUINOXALINE COMME INHIBITEURS DE PHOSPHODIESTÉRASES

Grunwald Christian; Hoefgen Norbert; Stange Hans; Dost Rita; Egerland Ute; Lankau Hans-Joachim; Langen Barbara

Archive | 2013

DERIVADOS DE (1,2,4)TRIAZOLO[4,3-A]QUINOXALINA COMO INHIBIDORES DE FOSFODIESTERASAS

Lankau Hans-Joachim; Langen Barbara; Grunwald Christian; Hofgen Norbert; Stange Hans; Dost Rita; Egerland Ute

Archive | 2013

Compuestos derivados de 1, 2, 4-triazolo [4,3-a] quinoxalina, inhibidores de pde2 y/o 10; composicion farmaceutica que los comprende; combinacion farmaceutica; y su uso para en el trastamiento de enfermedades del snc

Lankau Hans-Joachim; Langen Barbara; Hofgen Norbert; Stange Hans; Dost Rita; Egerland Ute; Grunwald Christian

Archive | 2011

4-amino-pirido[3,2-e]pirazinas, uso das mesmas como inibidores de fosfodiestrase 10 e processo para a preparação das mesmas

Hoefgen Norbert; Stange Hans; Langen Barbara; Egerland Ute; Schindler Rudolf; Pfeifer Thomas; Rundfeldt Chris

Archive | 2010

PIRIDO (3,2-E)PIRACINAS, SU USO COMO INHIBIDORES DE FOSFADIESTERASA 10, Y PROCESOS PARA PREPARARLAS.

Hofgen Norbert; Stange Hans; Langen Barbara; Egerland Ute; Schindler Rudolf; Pfeifer Thomas; Rundfeldt Chris

Explore More

Collaboration

Dive into the Egerland Ute's collaboration.

Top Co-Authors
Avatar

Hofgen Norbert

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors
Avatar

Langen Barbara

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors
Avatar

Rundfeldt Chris

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Schindler Rudolf

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors
Avatar

Lankau Hans-Joachim

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Dost Rita

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Dost Rita

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Lankau Hans-Joachim

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Ward Simon

Janssen Pharmaceutica

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge